Anthem Blue Cross Blue Shield's recent decision to limit anesthesia reimbursements highlights a troubling pattern of prioritizing profits over patient care, especially in oncology.
Memorial Sloan Kettering Cancer Center is treated unfairly by Anthem, receiving reimbursement rates 34% lower than those offered to similar cancer centers, risking patient care quality.
Despite efforts to negotiate, Anthem has opted for a public relations strategy to mislead patients and divert attention from the crucial issue of access to essential cancer treatments.
Every year, MSK treats over 60,000 cancer patients, with many depending on their advanced care models that are now threatened by Anthem’s refusal to provide fair compensation.
Collection
[
|
...
]